Provider review
Mojoon review
Its own three pages disagree on which states it serves
The only Mandarin- and Cantonese-first GLP-1 platform we found: semaglutide runs $350 to $520 a course, tirzepatide $390 to $490 a month. Three of its own pages give three different answers about which states it serves.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Mojoon's tirzepatide pricing is clearly itemized by dose, but check your specific state before enrolling — its own homepage, About page, and FAQ each state a different list of excluded states, and none of the three agree with each other. Its semaglutide page also headlines itself as "FDA-approved" while its own body text says the medication is compounded and non-FDA-approved.
Mojoon is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You want bilingual Mandarin/Cantonese support — the only platform found offering it in this category
- You want tirzepatide priced clearly by dose tier ($390–$490/month)
- You want a domain-matched LegitScript seal
Look elsewhere if
- You need certainty your state is covered — Mojoon's own pages disagree with each other on which states are excluded
- You're relying on the "FDA-Approved" headline on its semaglutide page — its own body text says the medication is compounded and non-FDA-approved
- You want a named physician — none is disclosed anywhere
What it actually costs
What they advertise
Compounded semaglutide runs $350–$520 per course on mojoon.com's own pricing page.
What you actually pay, month to month
Tirzepatide is priced by dose: $390/month for 2.5–10mg, rising to $490/month for 12.5–15mg.
The commitment trap
Mojoon's semaglutide page shows a $350–$520 course range that its own FAQ separately describes with a $450/month example, without clearly stating how long a "course" runs.
Checked live on Mojoon's own site at https://mojoon.com/ in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Mojoon bundles in, and what it does not.
Clinician consult
Not published.
Bloodwork / labs
Not published.
Follow-ups and dose changes
No cadence published.
Human support
Bilingual Mandarin/Cantonese support.
Injection supplies
Shipped via an FDA-registered 503A/503B compounding pharmacy.
Shipping
No timeline published.
Pharmacy, labs and oversight
The pharmacy
Described only as "an FDA-registered 503A/503B compounding pharmacy," VIPPS/NABP- and URAC-accredited; not individually named.
Oversight
No cadence published.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
Contradictory across Mojoon's own pages: its homepage claims 48 states (excluding New Mexico and Mississippi), its About page's printed list actually covers all 50 states plus DC, and a separate, visibly stale FAQ names a third exclusion list entirely.
The honest cons
The part they would rather you skipped
Mojoon's own homepage, About page, and FAQ each state a different list of which states it serves — and its semaglutide page headlines "FDA-Approved" while its own body text says the medication is a compounded, non-FDA-approved version of Wegovy/Ozempic.
- Three of its own pages disagree with each other on state coverage
- Semaglutide page headline says "FDA-Approved" while its own body text says compounded/non-FDA-approved
- No physician named anywhere
- FAQ page carries visibly stale 2023-dated content that contradicts the site's current live scope
None of this is unique to Mojoon — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. Mojoon is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Mojoon's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Mojoon's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.